Gene: DNAH2
Official Full Name: dynein axonemal heavy chain 2provided by HGNC
Gene Summary: Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. The axonemal dyneins, found in cilia and flagella, are components of the outer and inner dynein arms attached to the peripheral microtubule doublets. DNAH2 is an axonemal inner arm dynein heavy chain (Chapelin et al., 1997 [PubMed 9256245]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23968 | DNAH2 Knockout cell line (HCT 116) | Human | DNAH2 | 1:2~1:4 | Negative | Online Inquiry |
DNAH2 Gene Knockout Cell Lines represent a sophisticated tool utilized in genetic and biomedical research aimed at understanding the role of the DNAH2 gene in various physiological and pathological processes. These cell lines are engineered through precise gene-editing techniques, such as CRISPR/Cas9, to create a complete knockout of the DNAH2 gene, allowing researchers to investigate the consequences of the absence of this gene in cellular functions.
The primary function of the DNAH2 gene is tied to the encoding of an axonemal dynein protein, which is crucial for the movement of cilia and flagella, structures that play significant roles in cellular motility and signaling. By utilizing these knockout cell lines, scientists can dissect the molecular pathways affected by DNAH2 deficiency, shedding light on conditions related to motility disorders, such as primary ciliary dyskinesia (PCD). The mechanisms at play can be observed through various assays, including motility assessment, signal transduction evaluation, and comparative gene expression studies, leading to a deeper understanding of the gene's involvement in health and disease.
The scientific importance of DNAH2 gene knockout cell lines extends to both research and clinical applications. In the research realm, these lines serve as vital models for drug screening and identifying potential therapeutic targets for conditions involving ciliary dysfunction. Clinically, the insights gained may contribute toward advancing personalized medicine approaches and developing gene therapies for affected individuals.
One key advantage of our DNAH2 gene knockout cell lines is their ready-to-use format, facilitating expedited experimental design without the protracted development time typically required for generating knockout models. Additionally, our product benefits from rigorous quality control and validation processes, ensuring high reproducibility and reliability in various experimental conditions, which is paramount for scientists working in dynamic research environments.
For researchers and clinicians who are focused on elucidating the complexities of ciliary biology and related disorders, the DNAH2 gene knockout cell lines offer an invaluable resource. By leveraging our state-of-the-art selection and verification methods, users can be confident in their experimental outcomes, thereby accelerating their discoveries and innovations.
At our company, we pride ourselves on our expertise in developing cutting-edge biological products that empower researchers and drive advancements in science. With a commitment to quality and service, we continue to support the scientific community with innovative resources designed for impactful research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.